Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
135 |
|
Actual shortage: | 33 (24%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (76%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (45%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-FLUOXETINE | 20MG | CAPSULE | Resolved | 2018-07-31 | 2021-01-11 | 57069 |
MINT-CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-03 | 2019-11-29 | 71041 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-03 | 2019-01-16 | 71060 |
MINT-IRBESARTAN | 75MG | TABLET | Resolved | 2019-01-03 | 2021-07-12 | 71063 |
MINT-LOSARTAN | 100.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71066 |
MINT-LOSARTAN | 25.0MG | TABLET | Actual shortage | 2019-01-03 | 2020-01-27 | 71069 |
MINT-LOSARTAN | 50.0MG | TABLET | Resolved | 2019-01-03 | 2019-06-19 | 71074 |
MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-01-03 | 2019-02-07 | 71078 |
MINT-ROSUVASTATIN | 10MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71081 |
MINT-ROSUVASTATIN | 20MG | TABLET | Resolved | 2019-01-03 | 2019-02-01 | 71087 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-16 | 2021-08-11 | 72666 |
MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-02-04 | 2020-01-27 | 74450 |
MINT-METFORMIN | 500MG | TABLET | Actual shortage | 2019-02-04 | 2019-02-05 | 74455 |
MINT-HYDRALAZINE | 10MG | TABLET | Resolved | 2019-02-28 | 2019-09-03 | 77148 |
MINT-FENOFIBRATE E | 145MG | TABLET | Actual shortage | 2019-04-08 | 2020-04-25 | 80782 |
MINT-CANDESARTAN | 8MG | TABLET | Resolved | 2019-04-08 | 2019-06-15 | 80787 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80792 |
MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80797 |
MINT-IRBESARTAN | 150MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80800 |
MINT-IRBESARTAN | 300MG | TABLET | Resolved | 2019-04-08 | 2021-07-12 | 80803 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74435 | ||
MINT-CLOPIDOGREL | Discontinued | 2019-02-04 | 2019-02-05 | 74442 | ||
MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Discontinued | 2019-06-04 | 2019-06-04 | 85525 |
MINT-METFORMIN | 500MG | TABLET | Discontinued | 2019-07-04 | 2019-07-05 | 88513 |
MINT-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95897 |
MINT-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95900 |
MINT-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95903 |
MINT-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95907 |
MINT-SOLIFENACIN | 5MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95913 |
MINT-SOLIFENACIN | 10MG | TABLET | Discontinued | 2019-10-09 | 2019-10-10 | 95916 |
MINT-METFORMIN | 850MG | TABLET | Discontinued | 2020-03-09 | 2020-03-10 | 108292 |